#GLP1

Scientists have uncovered a potential natural alternative to Ozempic, the popular diabetes and weight-loss medication, by tapping into the power of gut microbes that can regulate blood sugar levels and curb sugar cravings. The latest research, led by a team from Jiangnan University in China and published in Nature Microbiology, points to the gut bacterium Bacteroides vulgatus and its metabolites as key players in stimulating the body’s natural production of glucagon-like peptide-1 (GLP-1), a hormone crucial for maintaining healthy blood sugar and satiety. While initial results are based on animal studies, this discovery raises fresh hope for safer, more accessible strategies to treat diabetes—potentially transforming the landscape for millions of people in Thailand and around the globe who struggle with blood sugar management and sugar cravings [ScienceAlert].

A social media fitness influencer with over five million followers has ignited a widespread controversy after publicly sharing that her recent weight loss success involved the use of a GLP-1 class medication, commonly known by names such as Ozempic and Mounjaro. The disclosure, made in a YouTube video titled “Let’s talk: Therapy, GLP-1 & The Truth About My Recent Weight Loss,” has set off heated discussions about transparency, ethical responsibility, and the realities of the online wellness industry.